[{"Assets_0_FY_USD":298969000.0,"CommonStockSharesOutstanding_0_FY_shares":36018540.0,"NetIncomeLoss_1_FY_USD":-10563000.0,"NetIncomeLoss_4_FY_USD":-31634000.0,"StockholdersEquity_0_FY_USD":209837000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170314"}]